norepinephrine-dopamine reuptake inhibitors (NDRIs)

norepinephrine-dopamine reuptake inhibitors (NDRIs)

« Back to Glossary Index

NDRIs (norepinephrine-dopamine reuptake inhibitors) are medications that block the reabsorption (reuptake) of specific neurotransmitters (norepinephrine and dopamine) after they have been excreted from a nerve cell. This inhibition of the reabsorption results in more activity of these specific neurotransmitters throughout the brain. NDRIs are commonly used to treat clinical depression, ADHD and narcolepsy. NDRI medications approved for use in the U.S. include methylphenidate (Ritalin), bupropion (Wellbutrin) and solriamfetol (Sunosi).



Get SomnusNooze, our e-newsletter

Sign up to receive HF updates, news from the world of sleep research, first-person stories, and more.

You will receive and email from (please check your junk/spam folder if needed) to confirm your subscription to our newsletter through MailChimp. You are not subscribed until you confirm. Thank you for your interest in Hypersomnia Foundation!